MetLife (MET) is trading down at $99.72 (-0.92%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Financials sector.
One firm's current price target on MetLife: $106 — 6% above the current $99.7. Each is tracked to its date and scored the same way a member's call is.
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $60.8B | $62.3B | $67.9B | $69.6B | $67.8B | $68.7B | $68.8B | $66.9B | $71.0B | $77.1B |
| Growth (year over year) | −0.9% | +2.5% | +9.0% | +2.5% | −2.6% | +1.3% | +0.1% | −2.7% | +6.1% | +8.6% |
| Operating income | — | — | — | — | — | — | $5.98B | $5.72B | $6.00B | $6.14B |
| Operating margin | — | — | — | — | — | — | 8.7% | 8.6% | 8.4% | 8.0% |
| Net income | $850.0M | $4.01B | $5.12B | $5.90B | $5.41B | $6.86B | $5.28B | $1.58B | $4.43B | $3.38B |
| Net margin | 1.4% | 6.4% | 7.5% | 8.5% | 8.0% | 10.0% | 7.7% | 2.4% | 6.2% | 4.4% |
| EPS (diluted) | $0.67 | $3.62 | $4.91 | $6.06 | $5.68 | $7.65 | $6.30 | $1.81 | $5.94 | $4.71 |
| Balance sheet | ||||||||||
| Cash and equivalents | $12.7B | $12.7B | $15.8B | $16.6B | $19.8B | $20.0B | $20.2B | $20.6B | $20.1B | $22.0B |
| Total assets | $898.8B | $719.9B | $687.5B | $740.5B | $795.1B | $759.7B | $663.1B | $687.6B | $677.5B | $745.2B |
| Total liabilities | $831.1B | $661.0B | $634.6B | $674.1B | $720.3B | $692.0B | $632.9B | $657.3B | $649.8B | $716.2B |
| Shareholders' equity | $67.5B | $58.7B | $52.7B | $66.1B | $74.6B | $67.5B | $29.9B | $30.0B | $27.4B | $28.4B |
| Cash flow | ||||||||||
| Operating cash flow | $14.8B | $12.3B | $11.7B | $13.8B | $11.6B | $12.3B | $13.0B | $13.7B | $14.6B | $17.1B |
| Dividends paid | $1.74B | $1.72B | $1.68B | $1.64B | $1.66B | $1.65B | $1.60B | $1.57B | $1.53B | $1.51B |
| Share buybacks | $372.0M | $2.93B | $3.99B | $2.29B | $1.15B | $4.30B | $3.33B | $3.10B | $3.21B | $2.88B |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $18.4B | $18.7B | $18.6B | $17.3B | $17.4B | $23.8B | $19.1B | $19.2B |
| Growth (year over year) | +16.2% | −1.9% | +15.6% | −2.7% | −5.9% | +27.6% | +2.7% | +10.5% |
| Operating income | $1.44B | $1.49B | $1.42B | $1.39B | $1.65B | $1.68B | $1.63B | $1.60B |
| Operating margin | 7.8% | 8.0% | 7.6% | 8.0% | 9.5% | 7.1% | 8.6% | 8.4% |
| Net income | $1.34B | $1.27B | $945.0M | $729.0M | $896.0M | $809.0M | $1.19B | $736.0M |
| Net margin | 7.3% | 6.8% | 5.1% | 4.2% | 5.2% | 3.4% | 6.2% | 3.8% |
| EPS (diluted) | $1.81 | $1.75 | $1.28 | $1.03 | $1.22 | $1.18 | $1.74 | $1.09 |
| Balance sheet | ||||||||
| Cash and equivalents | $21.8B | $20.1B | $21.3B | $22.2B | $20.2B | $22.0B | $22.7B | $19.3B |
| Total assets | $705.0B | $677.5B | $688.3B | $702.5B | $719.7B | $745.2B | $743.2B | $759.4B |
| Total liabilities | $673.8B | $649.8B | $660.6B | $674.5B | $690.5B | $716.2B | $715.4B | $731.4B |
| Shareholders' equity | $30.9B | $27.4B | $27.5B | $27.7B | $28.9B | $28.4B | $27.3B | $27.4B |
| Cash flow | ||||||||
| Operating cash flow | $4.17B | $4.61B | $4.26B | $2.19B | $3.57B | $7.08B | $2.69B | $2.23B |
| Dividends paid | $383.0M | $378.0M | $374.0M | $382.0M | $378.0M | $375.0M | $372.0M | $383.0M |
| Share buybacks | $774.0M | $406.0M | $1.41B | $510.0M | $502.0M | $460.0M | $755.0M | $722.0M |
From MetLife's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with around 90 million customers in over 60 countries. The firm was founded on March 24, 1868. MetLife ranked No. 43 in the 2018 Fortune 500 list of the largest United States corporations by total revenue.
MetLife at KBW Insurance Conference 2026: growth plan stays ahead
MetLife at KBW Insurance Conference 2026: growth plan stays ahead
Is MetLife Outperforming the Nasdaq?
Is MetLife Outperforming the Nasdaq?
Evercore ISI raises MetLife stock price target to $106 on earnings
Evercore ISI raises MetLife stock price target to $106 on earnings
MetLife (MET) Q2 2026 Earnings Call Transcript
MetLife (MET) Q2 2026 Earnings Call Transcript